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MitochondriaDysfunction of cardiac energy metabolism plays a critical role in many cardiac diseases, including heart failure,
myocardial infarction and ischemia–reperfusion injury and organ transplantation. The characteristics of these
diseases can be elucidated in vivo, though animal-free in vitro experiments, with primary adult or neonatal
cardiomyocytes, the rat ventricular H9c2 cell line or themouse atrial HL-1 cells, providing intriguing experimen-
tal alternatives. Currently, it is not clear howH9c2 andHL-1 cellsmimic the responses of primary cardiomyocytes
to hypoxia and oxidative stress. In the present study, we show that H9c2 cells are more similar to primary
cardiomyocytes than HL-1 cells with regard to energy metabolism patterns, such as cellular ATP levels, bioenerget-
ics, metabolism, function andmorphology of mitochondria. In contrast to HL-1, H9c2 cells possess beta-tubulin II, a
mitochondrial isoform of tubulin that plays an important role inmitochondrial function and regulation.We demon-
strate thatH9c2 cells are signiﬁcantlymore sensitive to hypoxia-reoxygenation injury in terms of loss of cell viability
andmitochondrial respiration, whereas HL-1 cells weremore resistant to hypoxia as evidenced by their relative sta-
bility. In comparison to HL-1 cells, H9c2 cells exhibit a higher phosphorylation (activation) state of AMP-activated
protein kinase, but lower peroxisome proliferator-activated receptor gamma coactivator 1-alpha levels, suggesting
that each cell type is characterized by distinct regulation of mitochondrial biogenesis. Our results provide evidence
that H9c2 cardiomyoblasts aremore energetically similar to primary cardiomyocytes than are atrial HL-1 cells. H9c2
cells can be successfully used as an in vitro model to simulate cardiac ischemia–reperfusion injury.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Ischemia–reperfusion (IR) injury mechanisms are complex and
numerous. They include disruption of ionic homeostasis, in particular
calcium, mitochondrial permeability transition, energetic and oxidative
stresses, induction of cell death by apoptosis, and necrosis [1–5]. Indeed,
existing studies show that cardiac dysfunction can be directly linked to
mitochondrial damage and depressed cellular energymetabolism [5–7].
Many aspects of cardiac IR injury are not yet fully understood. In addition
to organ models, like coronary artery occlusion, the ex vivo model of IR,
cold storage, and organ transplantation, cell in vitro models are used
to simulate cardiac IR injury. These models entail the use of cultured
neonatal/adult cardiomyocytes [8–11], mouse atrial HL-1 cells, or rat
ventricular H9c2 cells (myoblasts) [12–20]. Neonatal cardiomyocytesCS, citrate synthase; FBS, fetal
henylhydrazone; IR, ischemia–
receptor gamma coactivator 1-
boratory, Department of Cardiac
0 Innsbruck, Austria. Tel.: +43
sov).can be considered as a very useful model for cardiac ventricular
cells, in particular to study various adaptive mechanisms. This model
represents a homogeneous population of cardiac cells, offering numerous
experiments to simulate cardiac pathologies. However, the absence
of mitochondrial creatine kinase and increased levels/activity of
membrane-bound hexokinase allow assuming that neonatal cells are
more dependent on glucose and possess more glycolytic phenotype as
compared with adult cardiomyocytes. Hearts of fetal and newborn
mammalians therefore are more dependent on glycolysis, whereas
adult hearts are almost exclusively aerobic and mainly utilize free
fatty acids [21]. As a consequence, neonatal hearts are rather resistant
to hypoxia. Moreover, shortly after birth, cardiac cells lose their ability
to divide.
Both H9c2 and HL-1 cell lines are immortalized cells with a cardiac
phenotype, and both arewidely used for the analysis of cardiac IR injury
and ischemic preconditioning [22]. Currently, the experimental out-
comes of studies using these unique cell lines and their interpretations
suggest signiﬁcant differences between them. Although existing data
provide some indications that H9c2 cells can be a better model [6,23],
direct comparative studies of the main bioenergetic parameters of
H9c2 and HL-1 cell lines, under normal conditions and in response to
hypoxia and oxidative stress, are still missing. Therefore, the aim of
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teristics of H9c2 and HL-1 cell lines. It has been previously shown
that the bioenergetic patterns and metabolic and functional properties
of HL-1 cells are signiﬁcantly different from those of primary adult
cardiomyocytes. Some of these differences involve energy status and
key parameters of mitochondrial respiratory regulation, such as appar-
ent Km for ADP, the roles of creatine kinase system, and hexokinase
[24–26]. Our study compares the most important energy-related
characteristics of H9c2 and HL-1 cells, such as ATP levels, mitochondrial
biogenesis, morphology, interaction of mitochondria with cytoskeleton,
respiration of mitochondria, and sensitivity of the cells to hypoxia-
reoxygenation, by using mitochondrial confocal imaging, enzymatic
and high-resolution respirometry approaches.
AMP activated protein kinase (AMPK) and peroxisome proliferator-
activated receptor (PPAR) gamma coactivator 1-alpha (PGC-1α) are
among the most important signaling proteins in mitochondrial biogen-
esis and oxidative function. Therefore, in addition to mitochondrial
morphology, biogenesis and function, we investigated protein levels of
AMPK, P-AMPK and PGC-1α during basal conditions, hypoxia alone,
and hypoxia-reoxygenation. AMPK plays a key role as an energy sensor
in the cell; energetic stressors change the AMP/ATP ratio, stimulating
AMPK to regulate a variety of metabolic processes and pathways, like
glycolysis, glucose uptake (GLUT4 translocation) and fatty acid oxida-
tion [27]. PGC-1α is a key regulator of themitochondrial transcriptional
network. It co-activates PPARs to upregulate fatty acid oxidation and
induces the transcription of oxidative phosphorylation genes by
coactivating nuclear respiratory factors (NRF)-1 and -2, as well as mito-
chondrial transcription factor A (Tfam) [28]. Our results show that H9c2
cells demonstrate high ATP levels, mitochondrial mass and respiratory
activity, as well as higher vulnerability to hypoxia and oxidative stress
than HL-1 cells. Also, these cells exhibit higher levels of activated
AMPK, but lower levels of PGC-1α, with elevated responses to hypoxia
and the chemical AMPK activators metformin and A769662. Based on
patterns of energymetabolism and sensitivity to hypoxia, we concluded
that H9c2 cardioblastic cells could be a better model than HL-1 cells in
the study of mechanisms of hypoxia and ischemia reperfusion injuries.
2. Materials and methods
2.1. Cell cultures
H9c2 embryonic rat heart-derived (ventricular) cells (myoblasts)
from ATCC were cultured in Dulbecco's modiﬁed Eagle's medium
(DMEM), supplemented with 10% fetal bovine serum (FBS) under 95%
air/5% CO2, and subcultured when at 50–60% conﬂuence. Notably, a
higher degree of conﬂuence was associated with lower mitochondrial
respiratory activity (data not shown). HL-1 cells fromATCCwith cardiac
phenotypewere grown in ﬁbronectin–gelatine coated ﬂasks containing
Claycombmedium (“Sigma”) and supplemented with 10% FBS, 100 U/ml
penicillin, 100 μg/ml streptomycin, 2 mM L-glutamine and 0.1 mM
norepinephrine. Cells were cultured at 37 °C and 5% CO2. Experiments
were performed using cells between passages 10 and 14. Usually, new
cultures were re-established from frozen stocks every three months.
2.2. Hypoxia-reoxygenation
H9c2 and HL-1 cells were subjected to different times of hypoxia
(2–24 h) in a controlled hypoxic plastic chamber. In hypoxia experi-
ments, nitrogen was ﬂushed up to a partial oxygen pressure of about
0.4% and followed by 24 h of reoxygenation at 37 °C in some sets of ex-
periments. To simulate ischemia, the cell culture medium for hypoxia
was deprived of serum. Reoxygenationwas conducted in a normoxic in-
cubator at 37 °C by replacing the ischemicmediumwith normal culture
medium supplemented with FBS. The time control group consisted of
cells without the hypoxic stimulus kept in the reoxygenation buffer.
Cell viability was assessed by the Trypan blue exclusion test.2.3. Cellular respiration
Oxygen consumption of the cells was measured by high resolution
respirometry [5,29] using a titration-injection respirometer (Oroboros®
Oxygraph, Innsbruck, Austria) in culture growth medium, before
and after addition of the mitochondrial uncoupler carbonilcyanide
p-triﬂouromethoxyphenylhydrazone (FCCP, 4 μM) at 37 °C, assuming
anO2 solubility of 10.5 μmol l−1 kPa−1 (1.4 μmol l−1mmHg−1). DatLab
software (Oroboros, Innsbruck, Austria) was used for data acquisition
and analysis [5]. Respiration rates were expressed in pmol of O2 per
second per 106 cells. Both endogenous and uncoupled respiration
rates were linearly dependent on the cell density, in the range of
0.1–6.0 × 106 cells/ml. Also, mitochondria-speciﬁc inhibitors blocked
respiration, conﬁrming that oxygen consumption was due to the mito-
chondrial respiratory chain (data not shown).
2.4. ATP levels
Cellular ATP content wasmeasured using the bioluminescent somatic
cell assay kit (Sigma) and multiplate luminometer [29]. After protein
precipitation, ATP was extracted from cells using 0.5 M perchloric acid.
Subsequent neutralization with 1 M KCO3 and 100 mM HEPES was
followed by centrifugation at 10,000 g for 5 min to remove precipitates.
The ATP calibration curve was used for ﬁnal analysis.
2.5. Citrate synthase activity
Cellswere frozen in liquid nitrogen and stored at−80 ° C. The activity
of the mitochondrial matrix marker enzyme citrate synthase (CS) was
assayed spectrophotometrically by measuring coenzyme A formation at
412 nm, in cells at 30 ° C in the assay medium supplemented with 0.1%
Triton X-100 as described previously [29].
2.6. SDS-PAGE and Western blotting
Tissue samples from mouse brain, heart atrium, and left ventricle
were homogenized on ice in the lysis buffer containing 50 mM
Tris–HCl, 150 mM NaCl, 0.02% sodium azide, 0.1% SDS, 1.0% NP-40,
0.5% sodium deoxycholate, 10 mM sodium orthophosphate, 25 mM
glycero-2-phosphate, 25 mM NaF, pH 8.0, and supplemented with
1 mM PMSF, 0.2 mM Na-orthovanadate and proteinase inhibitor cock-
tail (“Calbiochem”). Insoluble material was removed by centrifugation
at 4 °C, and protein concentration was determined in the supernatant
using the BCA-Assay (Pierce) with bovine serum albumin as standard.
Cells (HL-1 and H9c2) were washed twice in phosphate-buffered
saline (PBS) without calcium and magnesium. Equal numbers of cells
were lysed by direct addition of protein sample buffer containing
60 mM Tris–HCl, 10% (wt/vol) glycerin, 3% sodium dodecyl sulfate
(wt/vol), 5% 2-mercaptoethanol (wt/vol), and 0.05% (wt/vol)
bromphenol blue, pH 6.8 and boiled at 100 °C for 5 min. Cell extracts
were separated on a 10% sodium dodecyl sulfate-polyacrylamide gel
and transferred to a nitrocellulose membrane in blotting buffer,
containing 25 mM Tris (pH 8), 190 mM glycine, and 20% methanol,
using a tank blot procedure. Blotting was performed at 400 mA for
60min at 4 °C. Themembranewas blocked for 1 h in TBS supplemented
with 0.05% Tween 20 (vol/vol) and 5% (wt/vol) nonfat dry milk
(“Sigma-Aldrich”). Incubation with the primary antibody against
murine beta-tubulin II (Abcam), appropriately diluted in TBS supple-
mented with 0.05% Tween 20 (vol/vol) and 5% (wt/vol) dry milk pow-
der, was carried out either at room temperature or overnight at 4 °C.
After three washes (10 min each) with TBS containing 0.05% Tween
20 (wt/vol), the blot was incubated with the appropriate (anti-rabbit)
horseradish peroxidase-linked (rb-HRP) secondary antibody (“Sigma-
Aldrich”), diluted 1:3000 in TBS supplemented with 0.05% Tween
20 (vol/vol) and 1.6% (wt/vol) dry milk powder for 45 min at room
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the enhanced chemiluminescence detection system (ECL, “Amersham”).2.7. Mitochondrial morphology and structural arrangement
Cells were placed in Lab-Tek chambered coverglass (Nalge Nunc,
Rochester, NY) with chamber volumes of 0.3 ml (~50 × 103 cells per
chamber). In order to analyze the mitochondrial arrangement of H9c2
and HL-1 cells, cells were incubated for 30 min at room temperature
with 50 nM tetramethylrodamine methyl ester (TMRM, “Sigma”).
TMRM ﬂuorescence was excited with a 543-nm helium–neon laser, at
a laser output power of 1 mW. The TMRM signal was redirected to a
560-nm long-pass ﬁlter and collected in a pinhole (one Airy disk unit).
TMRM ﬂuorescence was fully colocalized with mitochondrial ﬂavopro-
teins, integral components of the mitochondrial inner membrane (data
not shown), and mitochondria-speciﬁc probe MitoTracker (“Molecular
Probes”).2.8. Immunoﬂuorescence analysis
Cells were placed in chambered cover slides for 24 h (5–10 × 104
cells per chamber), ﬁxed with 4% PFA for 15 min at room temperature,
washed 3 times with PBS, and permeabilized with 0.1% Triton X-100
for 10 min at 4 °C. Cells were washed once with PBS and blocked with
1% BSA in PBS for 1 h at room temperature. Immunostaining using
primary antibodies against beta-tubulin II (“Abcam”, Novus Biochemi-
cals) was performed overnight at 4 °C. After three washes with PBS,
secondary antibodies (goat anti-mouse IgG Alexa Fluor 568 or goat
anti-mouse IgG FITC) were added and incubated for 1 h at room
temperature. In experiments with co-staining, cells were incubated
with 200 nM MitoTracker red (“Molecular Probes” Inc., Leiden,
Netherlands) for 30 min at 37 °C, prior to ﬁxation for visualization of
mitochondria.2.9. Statistical analysis
Data are presented as means ± SD. The statistical differences be-
tween groupswere calculated by two-tailed Student's t-test. Differences
were considered to be statistically signiﬁcant when P b 0.05.2c9H
A B
Fig. 1. Different mitochondrial organization/arrangement in H9c2 and HL-1 cells. Representati
strate punctuated/distinctmitochondria inH9c2 cells (visible also in adult primary cardiomyocy
Mitochondria were visualized by ﬂuorescent confocal microscopy using mitochondrial speciﬁc3. Results
3.1. Mitochondrial morphology
Our study analyzed mitochondrial morphology and structural
arrangement in HL-1 and H9c2 cells, using the mitochondria-speciﬁc
ﬂuorescent dyes, TMRM and MitoTtracker (Fig. 1). Confocal ﬂuorescent
imaging demonstrated relatively more fragmented (punctuated) mito-
chondria in H9c2 cells. We also observed clusters or long threads of
mitochondria surrounding nuclei, which may indicate a higher degree
of mitochondrial networking in HL-1 cells (arrow in Fig. 1).
Previous studies proposed that mitochondrial interactions with the
cytoskeleton, in particular, with the cytoskeletal protein beta-tubulin
II, played a crucial role in the regulation of cardiac energy metabolism
[30–32]. Therefore, we assessed the subcellular localization of beta-
tubulin II in H9c2 and HL-1 cells. Confocal immune-ﬂuorescent analysis
of ﬁxed cells revealed a remarkable difference between H9c2 and HL-1
cell lines; beta-tubulin II was clearly present in H9c2 cells and, in con-
trast, absent in HL-1 cells (Fig. 2AB). Cells that exhibit an absence of
beta-tubulin II have a different mode of regulation of mitochondrial re-
spiratory functions than adult primary cardiomyocytes or myocardial
tissue; differences exist with regard to patterns of energy metabolism,
apparent Km for ADP, creatine and glucose stimulatory effects, etc.
[24,25]. Hence, these studies propose that the interaction of mitochon-
dria with beta-tubulin II plays a key role in the regulation of energy
metabolism in the heart [30–32]. The absence of beta-tubulin II in HL-1
cells can also be explained by the cancerous phenotype of HL-1 cells.
They are derived from the AT-1 mouse atrial cardiomyocyte tumor line-
age, and perhaps rely mostly on cytoplasmic sources of ATP (glycolysis),
rather thanmitochondria-generated ATP. In our study, beta-tubulin II did
not colocalize with mitochondria (Fig. 2C) in H9c2 cells, although a close
localization of mitochondrial threads and beta-tubulin II ﬁlaments was
seen in some regions (arrows in Fig. 2C).
Confocal imaging data were conﬁrmed by protein analysis of beta-
tubulin II in various cells and tissues (Fig. 3). The analysis demonstrates
that beta-tubulin II was found in the brain, cardiac tissues (atrium and
ventricle), smoothmuscle cells (SMC), human umbilical vein endothelial
cells (HUVEC), and H9c2 cardiomyoblasts. In contrast, human colon
carcinoma DLD-1 cells demonstrated an absence of beta-tubulin II, and
only small traces of the protein were observed in HL-1 cells.
Thus, these data demonstrate that H9c2 and HL-1 cells have distinct
mitochondrial morphologies and structural arrangements. The presence1-LH
ve confocal imaging of mitochondrial organization in H9c2 (A) and HL-1 (B) cells demon-
tes) andmoremitochondrial network inHL-1 cellsmore typical for various cancerous cells.
probe TMRM (0.1 μM, see Methods). Bar, 20 μm.
H9c2 HL-1
A B
H9c2
C
Fig. 2. Confocal imaging of beta-tubulin II in H9c2 and HL-1 cells. Cells were ﬁxed and stained with antibodies against beta-tubulin II as described in Methods, using second antibodies
Fluoro-Nanogold-anti-mouse Fab′ antibodies bound to Alexa-Fluor-488. A: Note the presence of beta-tubulin II in H9c2 cells and absence in HL-1 cells (B). C: H9c2 cells were stained
with antibodies against beta-tubulin II (green) and additionally with MitoTracker red for visualization of mitochondria. In some regions, a close arrangement of mitochondrial threads
and tubulin ﬁlaments can be seen (arrows).
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bioenergetically more similar to primary cardiomyocytes.
3.2. Cellular ATP levels and mitochondrial bioenergetics
In the next set of experiments, we assessed whether any differences
existed betweenH9c2 andHL-1with regard to cellular ATP levels, respi-
ratory function of mitochondria and mitochondrial mass (content),β-Tubulin-II 
GAPDH
Fig. 3. Western blot analysis of beta-tubulin II in various cells and tissues. Similarly to
conﬁrming the results of ﬂuorescent confocal imaging (see Fig. 2), the presence of
beta-tubulin II in H9c2 cells and the absence in HL-1 cells were found. Note the abundant
amount of beta-tubulin II in rat and mice heart and in brain. All probes contained
app. 20 μg of total protein. GAPDH (“Ambion”) was used a loading control. DLD, human
colorectal carcinoma cells; HUVEC, human umbilical vein endothelial cells; SMS, smooth
muscle cells.evidenced by mitochondrial marker CS. As shown in Fig. 4A, ATP levels
and activity of CS, an indicator of mitochondrial mass, were more than
2-fold higher in H9c2 cells compared to HL-1 cells. Likewise, H9c2
cells are characterized by signiﬁcantly better respiratory function than
HL-1 cells, as evidenced by both higher cellular endogenous respiration
and uncoupled respiration (Fig. 4B). The uncoupling was performed by
step-wise increasing concentration of mitochondrial uncoupler FCCP
(1–5 μM). The uncoupled control ratio, calculated as the ratio of endog-
enous respiration to uncoupled respiration, was also higher in H9c2
cells than in HL-1 cells. Thus, these data indicate that ATP levels, mito-
chondrial respiration rates and mitochondrial mass are all signiﬁcantly
higher in H9c2 cardiomyoblasts than in HL-1 cells.
3.3. The effects of hypoxia-reoxygenation
Next, we studied the vulnerability of HL-1 and H9c2 cells to hypoxia
and hypoxia-reoxygenation-induced oxidative stress by determining
cell viability and respiration of mitochondria. Analysis of cell viability
demonstrated that H9c2 cells are more sensitive to hypoxia-
reoxygenation injury than HL-1 cells (Fig. 5A–D). Cell viability of H9c2
cells was 28% (P b 0.05) and 32% (P b 0.001) less than HL-1 cells at
16 h and 24 h after hypoxia, respectively (Fig. 5E). The cells exposed
to hypoxia-reoxygenation exhibited distinct levels of mitochondrial
dysfunction responses in a time-dependent manner. Mitochondrial
respiratory function was relatively stable in HL-1 cells, whereas it was
signiﬁcantly diminished in H9c2 cells after 6 h, 12 h and 24 h of hypoxia
and 24 h reoxygenation (Fig. 6). Notably, the results of mitochondrial
dysfunction correlated with cell survival data. After 24 h of hypoxia
and 24 h of reoxygenation, H9c2 and HL-1 cells displayed 64% and
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Fig. 4. Biochemical, bioenergetic properties and respiratory activities are different in H9c2
and HL-1 cells. A: H9c2 cells demonstrate signiﬁcantly higher level of ATP (per 106 cells)
and activity of mitochondrial marker enzyme citrate synthase (CS) as compared with
HL-1 cells. B: Both endogenous and uncoupled (by FCCP) respiration, as well as uncoupled
control ratio (UCR) are signiﬁcantly higher in H9c2 cells than in HL-1 cells (N = 3; *
P b 0.05; *** P b 0.001).
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tively, compared to corresponding control cells. Thus, these data
revealed that, in comparison to the HL-1 cells, H9c2 cells are highly
sensitive to hypoxia and oxidative stress, which can be due to the
high energy dependence (mitochondrial ATP) of these cells.
3.4. AMPK, and PGC-1α levels and effects of hypoxia-reoxygenation
AMPK and PGC-1α are two major signaling proteins in the regula-
tion of energy metabolism and mitochondrial biogenesis and function.
Their expression and activity in high energy consuming organs, like
the heart, provide strict control over cardiac energy metabolism. There-
fore, in the next series of experiments, we performed a comparative
analysis of protein levels of AMPK, P-AMPK and PGC-1α in H9c2 and
HL-1 cells, under control (normoxia) conditions, after hypoxia, and after
hypoxia-reoxygenation. Analysis of energymetabolismandmitochondri-
al function (see 3.2.) revealed signiﬁcant differences between H9c2 and
HL-1 cells. We observed a signiﬁcantly higher (about 3.2-fold) amount
of phospho-AMPK and only slightly elevated levels of total AMPK in
H9c2 cells compared to HL-1 cells (Fig. 7, red boxes). Interestingly, the
PGC-1α level in H9c2 cells was lower than in HL-1 cells. To deﬁne the
effects of hypoxia and oxidative stress on AMPK and PGC-1α, the cells
were exposed to 2 h-hypoxia alone and 2 h-hypoxia with subsequent
24 h-reoxygenation. AMPK activators, the anti-diabetic drug metformin
and a more speciﬁc compound A769662, were used as positive controls.
As expected, short hypoxia (2 h) increased activation of AMPK (high
P-AMPK level) in bothH9c2 andHL-1 cells. Both cell types demonstrated
similar responses (1.9-fold and 2.3-fold activation, respectively) toAMPK activation by hypoxia. Notably, in both cell types, a decline in
the levels of P-AMPK was observed after 24 h of reoxygenation
(Fig. 7A). Metformin had no effect on phosphorylation of AMPK at low
concentration (1 mM) (Fig. 7B); however, pre-treatment of the cells
with 4 mM metformin increased AMPK activation signiﬁcantly. The
effect was augmented (up to a 3-fold increase) by the speciﬁc activator
A769662 (0.1 mM) (Fig. 7C). Overall, different protein levels of
P-AMPK and PGC-1αwere observed in H9c2 and HL-1 cells in response
to normoxia and hypoxia.
4. Discussion
The present study is the ﬁrst to demonstrate that i) H9c2
cardiomyoblasts remarkably differ fromHL-1 cells with regard to energy
metabolism; they contain higher cellular ATP levels, mitochondrial mass
and respiration capacity than HL-1 cells, ii) protein contents of activated
AMPK (P-AMPK) are higher, but PGC-1α expression is lower in H9c2
cells than in HL-1 cells, and iii) H9c2 cells are more sensitive to hypoxia
and oxidative stress thanHL-1 cells; they exhibit increased cell death and
mitochondrial dysfunction after hypoxia-reoxygenation (features of
H9c2 and HL-1 cells are summarized in the Table 1). Analysis of basal
and uncoupled respiration of mitochondria revealed higher levels of
mitochondrial function in H9c2 cells (Fig. 4B). Notably, elevated values
were also observed in the uncoupling control ratio (ratio of FCCP stimu-
lated and basal respiration), suggesting a higher degree of mitochondrial
efﬁciency in H9c2 cells compared with HL-1 cells. This can be explained.
Firstly, HL-1 cells are adult immortalized atrial cells, whereas ventricular
H9c2 cells have an embryonic origin. Secondly, although HL-1 cells are
used to develop a heart-speciﬁc phenotype in vitro [15], they are derived
frommouse atrium,whereas H9c2 cells are derived from the rat left ven-
tricle. Furthermore, although HL-1 cells may proliferate and contract
(thoughwe used non-beatingHL-1 cells), H9c2 cells are undifferentiated
myoblasts. Although both cell lines possess a number of disadvantages,
they are the only cell lines able to substitute primary cardiomyocytes
in in vitro models of IR injury and other cardiac diseases. It is difﬁcult
to rationalize their validity, which depends on the research focus. Several
previous studies used HL-1 cells to investigate the cardiologic effects of
physiological and pathological conditions in vitro, including oxidative
stress, ischemia, hypoxia, hyperglycemia and hyperinsulinemia [33].
Similarly, H9c2 cells were widely used to study the effects, mechanisms,
and therapeutic interventions of hypoxia/reoxygenation, autophagy,
hypertrophy, insulin resistance, apoptosis, endoplasmic reticulum-
mitochondria interactions and cellular signaling [6,13,14,16,34–36], as
well as various differentiation aspects [37–39].
Our study demonstrates that the H9c2 cell model is more relevant
than the HL-1 cell model in the mimicking of IR injury for studies of
energy metabolism and mitochondrial function in the intact heart.
Ventricular cardiomyocytes have a higher content of mitochondria
than atrial cardiomyocytes, higher citrate synthase activity, more orga-
nized regulation, higher oxidative activity, greater ATP synthesis, and
greater efﬁciency of energy transfer, including phosphocreatine shut-
tling [40–42]. Although HL-1 cells are able to contract, some cells lose
this advantage after a few passages, and the increasing number of
non-beating cells,whichhave differentmetabolic proﬁles, compromises
the study and affects ﬁnal results. We employed non-beating HL-1 cells
in our study. Comparative analysis of primary adult cardiomyocytes and
HL-1 cells revealed a dramatic difference in the mechanisms of mito-
chondrial ATP synthesis regulation, and apparentKm for ADP in primary
cardiomyocytes was about 10 fold higher than in HL-1 cells [24,25].
Furthermore, the use of glucose as a major energy substrate by HL-1
cells is explained by the fact that they are cancerous cells. High levels
of hexokinase were previously observed in HL-1 cells, indicating a
glycolytic phenotype of energy metabolism, a common characteristic
of cancer cells (Warburg effect). TheWarburg effect postulates a defect
in respiration and mitochondrial oxidative phosphorylation together
with increased aerobic glycolysis in tumor cells. Lack of β-tubulin class
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Fig. 5. Increased sensitivity of H9c2 cells to hypoxia compared to HL-1 cells. A–D: Representative phase contrast microscopy of H9c2 andHL-1 cells. Representative phase contrast pictures
were taken before (A, C) and after (B, D) hypoxic treatment (0. 4% oxygen) for 16 h and reoxygenation for 24 h. H9c2 cells were almost completely lysed after hypoxia, whereas HL-1
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data of cell viability after 16 h and 24 h of hypoxia. N= 3; * P b 0.05; *** P b 0.001.
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basis of the Warburg effect, where high activity of mitochondria-
bound hexokinase 2 allows a direct utilization of mitochondrial ATP
for glucose phosphorylation and lactate production [40,41]. Most likely,
the Warburg effect is the main cause of the high dependence of HL-1
cells on glucose. H9c2 cell are derived from embryonic rat cardio-
myocytes; however, they are not cancerous cells. This is conﬁrmed, in
addition to mitochondrial function, by morphological features and
structural arrangements of mitochondria that are different in H9c2
andHL-1 cells (Fig. 1). Confocal ﬂuorescent imaging discovered a higher
number ofmitochondria in H9c2 and amore branched network in someregions of HL-1 cells. Importantly, electrically non-connected, distinct
mitochondria are a characteristic feature of primary cardiomyocytes,
whereas the organization of mitochondria as a branched network is
more typical in cancerous cells [24,30].
Previous ﬁndings strongly support the hypothesis that cytoskeletal
elements interact with mitochondria to control mitochondrial respira-
tion [32,42,43]. Primary adult cardiomyocytes and myocardial ﬁbers
demonstrated the regular arrangement of beta-tubulin II, fully co-
localized with mitochondria, whereas other beta-tubulin isoforms
(I, III and IV) were localized in the cytoplasm and differently organized
in these cells [31]. Based on co-localization of beta-tubulin II with
Fig. 6.Mitochondrial respiratory parameters of H9c2 and HL-1 cells after hypoxia-reoxy-
genation. Basal and FCCP-uncoupled respiration at 6 h, 12 h and 24 h after hypoxia and
standard time (2 h) of reoxygenation. In contrast to HL-1 cells (which demonstrate a sta-
bility), H9c2 cells show signiﬁcant decrease (up to 60% of control in respiration rates after
24 h of hypoxia). N= 3; * P b 0.05; *** P b 0.001.
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Fig. 7. ComparativeWestern blot analysis of AMPK, P-AMPK, and PGC-1α in H9c2 andHL-1
cells. A–C:Whereas a similar level of AMPKwas found in both cell lines, H9c2 cells demon-
strate signiﬁcantly higher amount of phospho-AMPK (activated, P-AMPK). In contrast,
higher level of PGC-1α was found in HL-1 cells as compared with H9c2 cells. A: Short
hypoxia (2 h) resulted in signiﬁcant activation of AMPK to P-AMPK, both in H9c2 and in
HL-1 cells. B: Treatment with 1mMof activator of AMPKmetformin had no effect. C: Treat-
mentwith higher (4mM) concentration ofmetformin showed an activation of AMPK,more
visible after treatment with speciﬁc activator A769662 (0.1 mM, 8 h).
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interact with voltage dependent anion channel (VDAC) and, therefore,
participate in the regulation of mitochondrial respiration. In contrast,
HL-1 cells were characterized by the complete absence of beta-tubulin
II. Our study conﬁrmed this phenomenon by both confocal imaging
and Western blot analysis, demonstrating almost complete absence
of beta-tubulin II in HL-1 cells (Figs. 2 and 3). Like HL-1 cells, colon
carcinoma DLD cells revealed no expression of beta-tubulin II, suggesting
their similarity and cancerous phenotype (Fig. 3).
The heart is the most energy consuming organ, and mitochondria
provide over 80% of the ATP required for adequate function of cardio-
myocytes. These featuresmake cardiomyocytes highly sensitive to hyp-
oxia and oxidative stress induced by cardiac ischemia-reperfusion and
myocardial infarction. In adult cardiomyocytes, hypoxia for 6 h or hyp-
oxia followed by reoxygenation resulted in a 59% and 51% decrease in
cellular viability, respectively [44]. The absence of oxygen blocks mito-
chondrial function, leading to energy and oxidative stresses and
resulting in severe mitochondrial and organ tissue injury [7,45,46].
Our results revealed that H9c2 cells were signiﬁcantly more sensitive
to hypoxia-reoxygenation, demonstrating greater cell death and reduc-
tion in mitochondrial respiration. To the best of our knowledge, ours is
theﬁrst study to provide comparative analysis of sensitivity of H9c2 and
HL-1 cells to oxidative stress, although several studies examine the
effects of hypoxia-reoxygenation in H9c2 or HL-1 cells individually
[19,22,47].
Mitochondrial biogenesis is regulated by two major signaling mole-
cules, AMPK and PGC-1α. At the same time, AMPK activation couldmark-
edly stimulate glucose uptake by increased translocation of GLUT4 to the
plasma membrane [48,49], and also by elevated GLUT4 expression [50].
AMPK activation therefore serves to defend against energy deﬁciency
via activation of glucose transport and oxidation of fatty acids [27,51,
52]. Since H9c2 andHL-1 cells showed distinctmitochondrial respiration,
mass and structural characteristics, we investigated expression of these
proteins and observed that they demonstrated different patterns under
normal and hypoxic conditions. High levels of activated AMPK in H9c2
cells were associated with higher functional activity, mitochondrial
mass, and mitochondrial biogenesis, compared to HL-1 cells (Fig. 7).
Growing evidence demonstrates that AMPK is also a critical regulator of
mitochondrial biogenesis through activation of PGC-1α [28,53], an
important regulator of transcription of many genes involved in mito-
chondrial energymetabolism [28] andmitochondrial physiology and
oxidation of glucose and fatty acids. Despite high P-AMPK levels, mito-
chondrial mass and number, H9c2 cells contained signiﬁcantly less
PGC-1α compared to HL-1 cells. Mitochondrial biogenesis can beregulated both by PGC-1α-dependent and PGC-1α-independentmech-
anisms. Also, the higher activation of AMPKmay be associated with the
lower PGC-1α levels in H9c2 cells.
Table 1
Metabolic, biochemical, bioenergetic and morphological differences between rat H9c2
ventricle and mouse HL-1 atrial cells with cardiac phenotype.
Parameter/criteria H9c2
cardiomyoblasts
HL-1 cells
Citrate synthase (CS)a
Mitochondrial marker
↑ ↓
ATP contenta
Cellular energy status
↑ ↓
Cellular/mitochondrial
State 3 maximal respiration
↑ ↓
Uncoupled respiration
Uncoupled control ratio (UCR)
↑
↑
↓
↓
Mitochondrial morphology
Discrete mitochondria
↑ ↓
Mitochondrial morphology
Mitochondrial network
↓ ↑
Tubulin beta-II
(mitochondrial isotype)
+ --
Sensitivity to hypoxia-reoxygenation ↑ ↓
Phospho-AMP activated protein kinase (pAMPK) ↑ ↓
PGC-1α ↓ ↑
a Calculated per 106 cells.
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sibility that post-translational modiﬁcation of existing PGC-1α proteins,
independently of upregulation of the gene, may be sufﬁcient to enhance
mitochondrial biogenesis in H9c2 cells. Post-translational modiﬁcations
through phosphorylation, acetylation, methylation, ubiquitination, and
O-linked N-acetylglucosylation have been shown to affect the PGC-1α
activity (reviewed in [54,55]. On the other hand,mitochondrial biogenesis
(mass) can be regulated through PGC-1α-independent mechanisms.
PGC-1αwas not required for exercise-induced mitochondrial biogenesis
in themouse skeletal muscle [56], underlining the complexity of the role
of PGC-1α in the regulation of mitochondrial biogenesis and respiratory
function. In addition, PGC-1αmRNA expression was remarkably low in
C2C12myoblasts under basal conditions. Also, pyruvate-induced increase
in mitochondrial biogenesis, mitochondrial protein expression, basal
respiratory rate, andmaximal oxidative capacitywere independent of in-
creases in PGC-1α and PGC-1β mRNA expression in C2C12 myoblasts
[57]. Our data suggest that regulation of mitochondrial biogenesis in
H9c2 cells, like in C2C12myoblasts, is independent of PGC-1α, suggesting
the existence of other pathways that regulate the oxidative capacity
of mitochondria. The identiﬁcation of the PGC-1α-independent path-
ways that regulate mitochondrial biogenesis will be of great interest in
future.
Overall, these data clearly indicate that the AMPK and PGC-1α-
associated regulatory programofmitochondrial biogenesis is rather dif-
ferent in HL-1 and H9c2 cells. In future, it would be interesting to inves-
tigate and compare AMPK-activated GLUT4 translocation, as well as
troponin I levels in these cells. Since H9c2 cells represent myoblasts
that are not yet differentiated into myotubes, it would also be interesting
to compare energy metabolism, mitochondrial biogenesis, morphology,
and function of H9c2 cells and primary adult cardiomyocytes.5. Conclusion
H9c2 cells were found to be closer to normal primary cardio-
myocytes with regard to their energymetabolism features. Like primary
cardiomyocytes, they are more sensitive to hypoxia than HL-1 cells and,
therefore, can be more suitable in the design of the in vitro model of
cardiac hypoxia-reoxygenation and myocardial infarction. Moreover, it
is appropriate to utilize H9c2 cells to study the mechanisms of cardiac
ischemia-reperfusion injury, to evaluate the efﬁciency of various
therapeutic interventions, and in cardioplegic and organ preservation
applications.Disclosures
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